World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00005048
Date of registration: 30/07/2014
Prospective Registration: No
Primary sponsor: Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Public title: Training intervention with Palliative Patients (TiPP) - pilot study
Scientific title: Training intervention with Palliative Patients (TiPP) - pilot study - TiPP
Date of first enrolment: 11/12/2013
Target sample size: 25
Recruitment status: Recruiting stopped after recruiting started
URL:  http://drks.de/search/en/trial/DRKS00005048
Study type:  interventional
Study design:  Allocation: N/A: single arm study; Masking: Open (masking not used); Control: uncontrolled; Assignment: single; Study design purpose: treatment  
Phase:  N/A
Countries of recruitment
Germany
Contacts
Name: Gerhild    Becker
Address:  Robert-Koch-Straße 3 79106 Freiburg Germany
Telephone: +49 761 270-95412
Email: gerhild.becker@uniklinik-freiburg.de
Affiliation:  Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Name: Gerhild    Becker
Address:  Robert-Koch-Straße 3 79106 Freiburg Germany
Telephone: +49 761 270-95412
Email: gerhild.becker@uniklinik-freiburg.de
Affiliation:  Klinik für Palliativmedizin, Universitätsklinikum Freiburg
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria of palliative care patients:
- palliative patients
- = 18 years
- life expectancy 6-12 months
- ECOG: = 2
- numerical rating scale for pain = 3
- adequate cognitive status

Exclusion criteria: Exclusion criteria:
- neurological or orthopaedic diseases
- osseous metastases
- heart diseases: NYHA III-IV
- hypertensive emergency last 12 months
- bleeding tendency
- dyspnea during movement (VRS = 2)


Age minimum: 18 Years
Age maximum: None
Gender: All
Health Condition(s) or Problem(s) studied
All diseases needing palliative care.
Intervention(s)
Group 1: The exercise program consists of a strength- (KE) and a balance-endurance-flexibility-training (GABE) and has a length of 6 weeks. All exercises should be executed not exceeding 13-14 point on Borg Scale (range 6-20).
KE is performed three times per week (35 minutes) and GABE two times (25-30 minutes).
Primary Outcome(s)
De Morton Mobility Index (DEMMI); questionnaire: mobility; measurement after 3 and 6 weeks ///
Caregiver:
IRES-24; questionnaire: health status and physical functioning; measurement after 3 and 6 weeks
Secondary Outcome(s)
All measurements on week 3 and 6:
Patients:
- QLQ-C30; questionnaire: quality of life
- balance path length for Rombergstand via force plate
- 6 Minute Walk Test (6MWT); distance walked
- Barthel Index (BI); questionnaire: activities of daily living
- Five Times Sit to Stand Test (FTSS) on a force plate; repetitions
- Hand grip strength; Newton
- Qualitative interviews after intervention (nur bei T2)
/// Caregiver: - balance path length for Rombergstand via force plate
- Hand grip strength; Newton
- 30s chair stand test; repetitions
Secondary ID(s)
Source(s) of Monetary Support
Klinik für Palliativmedizin
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 25/06/2013
Contact:
ekfr.mpg@uniklinik-freiburg.de
Ethik-Kommission der Albert-Ludwigs-Universität Freiburg
+49-761-27072600
ekfr.mpg@uniklinik-freiburg.de
Results
Results available: Yes
Date Posted: 02/10/2015
Date Completed: 31/01/2014
URL: http://drks.de/search/en/trial/DRKS00005048#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history